Novo Nordisk brand
Novo Nordisk has developed a strategic response to how we can establish a clearly differentiated corporate position in the global diabetes market.
Our brand promise to our key stakeholders is as follows:
| Novo Nordisk is leading the fight against diabetes. Defeating diabetes is our passion and our business. |
Novo Nordisk has a strong starting point as a focused global diabetes company that cares.
Our long-term aspiration of defeating diabetes, working in partnership toward the common goals of prevention, detection, and treatment, remains our reason for being. We strive to achieve these goals through the Novo Nordisk Way of Management, as governed by our Triple Bottom Line. The Triple Bottom Line balances our commitment to:
- Our shareholders
- The environment
- Society
Our approach to doing business, which places the interests of people with diabetes at the core, is an important differentiator for us, especially as the pharmaceutical industry comes under ever closer scrutiny for its ethical conduct. We all have a role to play in being much more visible and in proactively communicating our leadership.
